GlassScriptPhysician profile
Stacia Royes
NPI 1033755962
$2,993.66
in general payments reported to CMS, 2019-2025
21 companies · $597 in 2025
The $597 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $346 · 2022: $600 · 2023: $601 · 2024: $850 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $886.33 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $450.91 | 2022-2025 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $225.48 | 2021-2025 | |
| Glaxosmithkline, LLC. | $220.12 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $200.55 | 2021-2024 | Mounjaro, Trulicity |
| Merck Sharp & Dohme LLC | $131.40 | 2021-2023 | Verquvo, Steglatro |
| Boston Scientific Corporation | $124.96 | 2023 | Watchman Access System |
| Amgen INC. | $115.65 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $102.11 | 2021-2024 | Xarelto |
| Exact Sciences Corporation | $97.43 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.60 | 2022-2025 | Jardiance |
| Medicomp INC | $65.81 | 2025 | Telepatch Cardiac Monitor |
| Cvrx, INC. | $59.69 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $43.47 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $41.54 | 2021-2023 | Camzyos |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $35.29 | 2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $27.72 | 2024 | |
| Abiomed | $23.47 | 2025 | |
| Irhythm Technologies, INC. | $20.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.76 | 2024 | Xifaxan |
| Edwards Lifesciences Corporation | $14.43 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacia Royes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.